3.A Case of Cap Polyposis Successfully Managed with Infliximab.
Dong Il KIM ; Yoon Tae JEEN ; Sang Hoon PARK ; Hwang Rae CHUN ; Chang Won BAECK ; Yong Sik KIM ; Hoon Jai CHUN ; Hong Sik LEE ; Soon Ho UM ; Jai Hyun CHOI ; Chang Duck KIM ; Ho Sang RYU ; Bong Kyung SHIN ; Jin Hai HYUN
Korean Journal of Gastrointestinal Endoscopy 2005;31(3):180-184
Cap polyposis is a rare disorder characterized by bloody, mucoid diarrhea with rectosigmoid polyps covered by a cap of fibrinopurulent exudate. The etiology and pathogenesis of cap polyposis is unknown, and no specific treatment has been established. Drug therapies are usually unsuccessful. Patients with a solitary cap polyp respond well to endoscopic polypectomy, while patients with multiple polyps and concurrent anorectal pathology require surgical resection. However, rapid recurrence has been described after a limited surgical resection, and this necessitates panproctocolectomy. We report a case of a 58-year-old female diagnosed as cap polyposis on rectum with similar clinical and endoscopic features of pseudomenbranous colitis successfully treated with infliximab (murine chimeric monoclonal antibody to TNF-alpha).
Colitis
;
Diarrhea
;
Drug Therapy
;
Enterocolitis, Pseudomembranous
;
Exudates and Transudates
;
Female
;
Humans
;
Middle Aged
;
Pathology
;
Polyps
;
Rectum
;
Recurrence
;
Infliximab
4.A Case of Rifampicin associated Pseudomembranous Colitis.
The Korean Journal of Gastroenterology 2004;43(6):376-379
Pseudomembranous colitis is a dangerous but unusual side effect of antibiotics usage. We report a case of pseudomembranous colitis that developed in a 50-year-old female patient with diabetes mellitus during first line anti-tuberculous therapy including rifampicin. The patient was diagnosed with active pulmonary tuberculosis 70 days earlier. On admission, she suffered intermittent abdominal pain and watery diarrhea for 2 weeks. Colonoscopy revealed exudative, punctuate, raised plaques with skip areas or edematous hyperemic mucosa, and histopathologic findings were consistent with pseudomembranous colitis with typical volcano-like exudate. Symptoms improved on treatment with metronidazole. There was no recurrence after reinstitution of the anti-tuberculous agents excluding rifampicin. In patients with persistent diarrhea receiving anti-tuberculosis treatment, rifampicin associated pseudomembranous colitis should always be kept in mind.
Antibiotics, Antitubercular/*adverse effects
;
English Abstract
;
Enterocolitis, Pseudomembranous/*chemically induced/diagnosis/drug therapy
;
Female
;
Humans
;
Middle Aged
;
Rifampin/*adverse effects
;
Tuberculosis, Pulmonary/drug therapy
5.Medulloblastoma and Familial Adenomatous Polyposis in a 24-year-old Female Patient: A Case Report of Turcot Syndrome.
Soo In JEONG ; Jung Min SUH ; Ji Hyuk LEE ; Hae Jung LEE ; Jee Hyun LEE ; Ki Woong SUNG ; Hye Jung SONG ; Yon Ho CHOE
Korean Journal of Pediatric Gastroenterology and Nutrition 2007;10(2):206-210
Turcot syndrome is characterized by the concurrence of a primary neuroepithelial brain tumor and multiple colorectal polyposis. We report a case of a 24-year-old woman diagnosed with Turcot syndrome. At first, the patient was diagnosed as having a medulloblastoma after a tumorectomy of the 4th ventricle mass. The patient underwent radiotherapy and chemotherapy. After high-dose chemotherapy, neutropenic fever and severe mucositis developed. For an evaluation of the persistent hematochezia and diarrhea, a colonoscopy was performed. It revealed pseudomembranous colitis and multiple polyps in the entire colon. According to the family history, her father had undergone a total colectomy due to colon cancer and polyposis of the entire colon. Her brother also was found to have multiple polyps in the colon by a colonoscopy. The patient was diagnosed with Turcot syndrome.
Adenomatous Polyposis Coli*
;
Brain Neoplasms
;
Colectomy
;
Colon
;
Colonic Neoplasms
;
Colonoscopy
;
Diarrhea
;
Drug Therapy
;
Enterocolitis, Pseudomembranous
;
Fathers
;
Female*
;
Fever
;
Gastrointestinal Hemorrhage
;
Humans
;
Medulloblastoma*
;
Mucositis
;
Polyps
;
Radiotherapy
;
Siblings
;
Young Adult*
6.A Case of Pseudomembranous Colitis Associated with Rifampin.
Ji Young PARK ; Joon Seok KIM ; Sun Jong JEUNG ; Myung Sook KIM ; Seok Chan KIM
The Korean Journal of Internal Medicine 2004;19(4):261-265
Pseudomembranous colitis is known to develop with long-term antibiotic administration, but antitubercular agents are rarely reported as a cause of this disease. We experienced a case of pseudomembranous colitis associated with rifampin. The patient was twice admitted to our hospital for the management of frequent bloody, mucoid, jelly-like diarrhea and lower abdominal pain that developed after antituberculosis therapy that included rifampin. Sigmoidoscopic appearance of the rectum and sigmoid colon and mucosal biopsy were compatible with pseudomembranous colitis. The antitubercular agents were discontinued and metronidazole was administered orally. The patient's symptoms were resolved within several days. The antituberculosis therapy was changed to isoniazid, ethambutol and pyrazinamide after a second bout of colitis. The patient had no further recurrence of diarrhea and abdominal pain. We report here on a case of pseudomembranous colitis associated with rifampin.
Aged
;
Aged, 80 and over
;
Antibiotics, Antitubercular/*adverse effects
;
Diarrhea/etiology
;
Enterocolitis, Pseudomembranous/*chemically induced
;
Humans
;
Male
;
Rifampin/*adverse effects
;
Tuberculosis, Pulmonary/drug therapy
7.A Case of Clostridium difficile Bacteremia in a Patient with Loop Ileostomy.
Jae Lim CHOI ; Bo Ram KIM ; Ji Eun KIM ; Kwang Sook WOO ; Kyeoung Hee KIM ; Jeong Man KIM ; Su Ee LEE ; Jin Yeong HAN
Annals of Laboratory Medicine 2013;33(3):200-202
Clostridium difficile, an anaerobic, spore-forming, gram-positive, rod-shaped bacterium, is the most common nosocomial pathogen causing pseudomembranous colitis. C. difficile is not intrinsically invasive and rarely infects extraintestinal sites. The bacterium, therefore, is not commonly detected in blood cultures. Here, we report a case of C. difficile bacteremia in a patient who had underwent loop ileostomy because of rectal obstruction following metastatic colon cancer originated from prostate cancer.
Anti-Bacterial Agents/*therapeutic use
;
Bacteremia/*drug therapy
;
Clostridium difficile/genetics/*isolation & purification
;
Colonic Neoplasms/pathology/secondary
;
Enterocolitis, Pseudomembranous/drug therapy/microbiology
;
Humans
;
Ileostomy
;
Male
;
Middle Aged
;
Prostatic Neoplasms/pathology
;
RNA, Ribosomal, 16S/chemistry/genetics
;
Sequence Analysis, RNA
8.A Case of Clostridium difficile Bacteremia in a Patient with Loop Ileostomy.
Jae Lim CHOI ; Bo Ram KIM ; Ji Eun KIM ; Kwang Sook WOO ; Kyeoung Hee KIM ; Jeong Man KIM ; Su Ee LEE ; Jin Yeong HAN
Annals of Laboratory Medicine 2013;33(3):200-202
Clostridium difficile, an anaerobic, spore-forming, gram-positive, rod-shaped bacterium, is the most common nosocomial pathogen causing pseudomembranous colitis. C. difficile is not intrinsically invasive and rarely infects extraintestinal sites. The bacterium, therefore, is not commonly detected in blood cultures. Here, we report a case of C. difficile bacteremia in a patient who had underwent loop ileostomy because of rectal obstruction following metastatic colon cancer originated from prostate cancer.
Anti-Bacterial Agents/*therapeutic use
;
Bacteremia/*drug therapy
;
Clostridium difficile/genetics/*isolation & purification
;
Colonic Neoplasms/pathology/secondary
;
Enterocolitis, Pseudomembranous/drug therapy/microbiology
;
Humans
;
Ileostomy
;
Male
;
Middle Aged
;
Prostatic Neoplasms/pathology
;
RNA, Ribosomal, 16S/chemistry/genetics
;
Sequence Analysis, RNA
9.A Case of Pseudomembranous Colitis after Voriconazole Therapy.
Jae Cheol KWON ; Min Kyu KANG ; Si Hyun KIM ; Su Mi CHOI ; Hee Je KIM ; Woo Sung MIN ; Dong Gun LEE
Yonsei Medical Journal 2011;52(5):863-865
This is a case report on a 35-year-old man with acute myelogenous leukemia who presented fever and intermittent mucoid loose stool to the emergency center. He had been taking voriconazole for invasive pulmonary aspergillosis. The flexible sigmoidoscopy was consistent with the diagnosis of pseudomembranous colitis.
Adult
;
Antifungal Agents/*adverse effects
;
Enterocolitis, Pseudomembranous/*chemically induced/pathology
;
Humans
;
Invasive Pulmonary Aspergillosis/complications/drug therapy
;
Leukemia, Myeloid, Acute/complications
;
Male
;
Opportunistic Infections/complications/drug therapy
;
Pyrimidines/*adverse effects
;
Triazoles/*adverse effects
10.Treatment of Refractory or Recurrent Clostridium difficile Infection.
The Korean Journal of Gastroenterology 2012;60(2):71-78
The incidence and severity of Clostridium difficile infection (CDI) has increased over the past decades. It is related to the emergence of hypervirulent strains and increased use of antibiotics. The incidence of refractory CDI to standard therapies and the risk for recurrent CDI are also increasing. Current guidelines recommend the first recurrence to be treated with the same agent used for the initial episode. However, data are lacking to support any particular treatment strategy for severe refractory CDI or cases with multiple recurrence. Treatments currently available for CDI are inadequate to prevent recurrence. Widely used method for managing a subsequent recurrence involves tapering followed by pulsed doses of vancomycin. Other potentially effective strategies for recurrent CDI are use of other antibiotics such as fidaxomicin, nitazoxanide, rifaximin, tigecycline, and teicoplanin. There are efforts to recover gut microflora and to optimize immune response to CDI. These include use of probiotics, fecal microbiota transplantation, intravenous immunoglobulin, monoclonal antibodies directed against C. difficile toxins, and active vaccination. However treatment of patients with refractory CDI and those with multiple CDI recurrences is based on limited clinical evidence, and there is an ongoing need for continued research to improve the outcomes these patients.
Anti-Bacterial Agents/therapeutic use
;
Antibodies, Monoclonal/immunology/therapeutic use
;
Clostridium difficile/drug effects/pathogenicity
;
Enterocolitis, Pseudomembranous/*drug therapy
;
Humans
;
Immunoglobulins, Intravenous/therapeutic use
;
Probiotics/therapeutic use
;
Recurrence
;
Vancomycin/therapeutic use